Skip to main content

Question for Department of Health and Social Care

UIN 132082, tabled on 12 March 2018

To ask the Secretary of State for Health and Social Care, what progress has been made on negotiations between NHS England and Vertex Pharmaceuticals on access to the drug Orkambi for people with cystic fibrosis.

Answered on

20 March 2018

NHS England is currently in discussion with Vertex about its range of drugs for treating cystic fibrosis, including the drug Orkambi. NHS England will continue to support discussions with pharmaceutical companies that aim to provide clinically effective medicines to patients at a level that is cost-effective, in line with standard National Institute for Health and Care Excellence practice for assessing new drugs before they are introduced into the National Health Service.